BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 28, 2011
 |  BC Week In Review  |  Company News  |  Other News

PDL BioPharma, AstraZeneca infectious news

PDL paid $92.5 million to AstraZeneca's MedImmune LLC subsidiary to settle a patent dispute related to MedImmune's respiratory syncytial virus drug Synagis palivizumab. As part of the settlement, MedImmune will not make any more payments to PDL for...

Read the full 190 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >